Mary Mullen, MD, PhD
Director, Pulmonary Hypertension Service; Senior Associate Cardiologist, Department of Cardiology
Associate Professor of Pediatrics, Harvard Medical School
Image
Mary Mullen, MD, PhD
Director, Pulmonary Hypertension Service; Senior Associate Cardiologist, Department of Cardiology
Associate Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Harvard College
1983
Cambridge
MA
Medical School
Harvard Medical School
1991
Boston
MA
Internship
Massachusetts General Hospital
1992
Boston
MA
Residency
Massachusetts General Hospital
1997
Boston
MA
Fellowship
Boston Children's Hospital
1999
Boston
MA
Fellowship
Massachusetts General Hospital
1999
Boston
MA
Media
Caregiver Profile
Meet Dr. Mary Mullen
Certifications
American Board of Internal Medicine (General)
American Board of Internal Medicine (Adult Congenital Heart Disease)
American Board of Pediatrics (General)
American Board of Pediatrics (Cardiology)
Publications
Pulmonary Hemodynamics and Long-Term Outcomes in Children withPulmonary Hypertension-Associated Bronchopulmonary Dysplasia. View Abstract
International Society for Heart and Lung Transplantation Consensus Statement on the Referral and Selection of Pediatric Lung Transplant Candidates. View Abstract
Neighborhood Child Opportunity Index and Outcomes in Pediatric Pulmonary Hypertension. View Abstract
Enhancing Drug Development for Paediatric Pulmonary Hypertension-An Integrative Perspective. View Abstract
Procedural Variation May Contribute to 6-Minute Walk Distance Variability in Real-World Pediatric Pulmonary Arterial Hypertension Study. View Abstract
Anxiety and Depression Screening of Youth in Pediatric Pulmonary Hypertension Clinic: A Multi-Center, Cross-Sectional Study. View Abstract
Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy: An Official American Thoracic Society Clinical Practice Guideline. View Abstract
SOX17-Associated Pulmonary Hypertension in Children: A Distinct Developmental and Clinical Syndrome. View Abstract
Actigraphy Study Endpoints to Reduce Sample Size and Facilitate Drug Development for Pediatric Pulmonary Arterial Hypertension. View Abstract
An interdisciplinary consensus approach to pulmonary hypertension in developmental lung disease. View Abstract
Correlation of Transthoracic Echocardiographic Estimates of Right Ventricular Pressure with Right Ventricular Pressure Measurements on Cardiac Catheterization in Children with Pulmonary Hypertension. View Abstract
Disparities in Healthcare Utilization: An Analysis of Disease Specific and Patient Level Factors in a Congenital Diaphragmatic Hernia Clinic. View Abstract
Exercise-Induced Pulmonary Hypertension in Long-Term Survivors of Congenital Diaphragmatic Hernia. View Abstract
Childhood Pulmonary Embolism: Characterizing a Critical and Challenging Diagnosis. View Abstract
Actigraphy methodology in the Kids Mod PAH trial: Physical activity as a functional endpoint in pediatric clinical trials. View Abstract
Kids Mod PAH trial: A multicenter trial comparing mono- versus duo-therapy for initial treatment of pediatric pulmonary hypertension. View Abstract
Measurement of Physical Activity by Actigraphy in Infants and Young Children with Pulmonary Arterial Hypertension. View Abstract
Transcatheter Ductus Arteriosus Stenting for Acute Pediatric Pulmonary Arterial Hypertension is Associated with Improved Right Ventricular Echocardiography Strain. View Abstract
Long-Term Functional Outcomes at 1-Year After Hospital Discharge in Critically Ill Neonates With Congenital Diaphragmatic Hernia. View Abstract
Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not? View Abstract
Pulmonary Hypertension in Infants and Children with Vein of Galen Malformation and Association with Clinical Outcomes. View Abstract
Molecular Function and Contribution of TBX4 in Development and Disease. View Abstract
An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations. View Abstract
JACC:Advances View Abstract
Metabolomics in Single Ventricle Heart Disease: Glimpsing the Pathobiology of Stage 2 Palliation. View Abstract
Understanding Genotype-Phenotype Correlations in Patients with TBX4 Mutations: New Views Inside and Outside the Box. View Abstract
Of Registries and Disease Classification: Unmasking the Challenges of Pediatric Pulmonary Hypertension. View Abstract
Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. View Abstract
Factors determining change in treatment for ambulatory children with pulmonary arterial hypertension: Implications for monitoring. View Abstract
Outcomes for Children With Pulmonary Hypertension Undergoing Tracheostomy Placement: A Multi-Institutional Analysis. View Abstract
Cardiac Catheterization and Hemodynamics in a Multicenter Cohort of Children with Pulmonary Hypertension. View Abstract
Case 2-2022: An Adolescent Male in Cardiac Arrest 3 Days After Liver Transplantation for End-Stage Liver Disease. View Abstract
Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia. View Abstract
Supraventricular Tachycardia in Infants With Congenital Diaphragmatic Hernia: Prevalence, Associations, and Outcomes. View Abstract
Recovery of right ventricular function after bilateral lung transplantation for pediatric pulmonary hypertension. View Abstract
Serial cardiac biomarker assessment in adults with congenital heart disease hospitalized for decompensated heart failure?. View Abstract
Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. View Abstract
High altitude simulation testing in patients with congenital diaphragmatic hernia. View Abstract
Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary Hypertension. View Abstract
Isolation and Culturing Primary Chaolangiocytes from Mouse Liver. View Abstract
A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. View Abstract
Lower oxygen saturation targets in preterm infants are not associated with increased rates of pulmonary hypertension. View Abstract
Prostanoids in pediatric pulmonary hypertension: clinical response, time-to-effect, and dose-response. View Abstract
Long-Term Fate of the Truncal Valve. View Abstract
Prenatal duct closure leading to severe pulmonary hypertension in a preterm neonate-a case report. View Abstract
Pharmacokinetics of Oral Treprostinil in Children With Pulmonary Arterial Hypertension. View Abstract
Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources. View Abstract
Longitudinal Analysis of Ventilation Perfusion Mismatch in Congenital Diaphragmatic Hernia Survivors. View Abstract
Phenotype characterisation of TBX4 mutation and deletion carriers with neonatal and paediatric pulmonary hypertension. View Abstract
Standardized outcomes in reproductive cardiovascular care: The STORCC initiative. View Abstract
Improving Safety of Intravenous Prostacyclin Administration to Pediatric Patients With Pulmonary Hypertension. View Abstract
Oral treprostinil in transition or as add-on therapy in pediatric pulmonary arterial hypertension. View Abstract
Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry. View Abstract
Feature extraction for phenotyping from semantic and knowledge resources. View Abstract
Pulmonary Artery Banding in Post-tricuspid Congenital Cardiac Shunting Defects with High Pulmonary Vascular Resistance. View Abstract
The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary Hypertension. View Abstract
Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia. View Abstract
A Computable Phenotype Improves Cohort Ascertainment in a Pediatric Pulmonary Hypertension Registry. View Abstract
Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension. View Abstract
Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. View Abstract
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. View Abstract
Lung Pathology in Pediatric Pulmonary Vein Stenosis. View Abstract
Central venous line complications with chronic ambulatory infusion of prostacyclin analogues in pediatric patients with pulmonary arterial hypertension. View Abstract
Chromosome microarray testing for patients with congenital heart defects reveals novel disease causing loci and high diagnostic yield. View Abstract
Response. View Abstract
Quality of life and parental adjustment in pediatric pulmonary hypertension. View Abstract
Pulmonary hypertension associated with scurvy and vitamin deficiencies in an autistic child. View Abstract
Right heart failure: toward a common language. View Abstract
Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. View Abstract
Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: initial clinical experience. View Abstract
Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. View Abstract
Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. View Abstract
Bilateral lung transplant for hereditary hemorrhagic telangiectasia in a pediatric patient. View Abstract
Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. View Abstract
Pulmonary arterial hypertension: what the large pulmonary arteries tell us. View Abstract
Pulmonary arterial hypertension in infants with chronic lung disease: will we ever understand it? View Abstract
Diagnostic strategies for acute presentation of pulmonary hypertension in children: particular focus on use of echocardiography, cardiac catheterization, magnetic resonance imaging, chest computed tomography, and lung biopsy. View Abstract
Lung abscess in adults with tetralogy of fallot and pulmonary atresia. View Abstract
Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia. View Abstract
The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population. View Abstract
Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. View Abstract
Cardiovascular malformations in Fryns syndrome: is there a pathogenic role for neural crest cells? View Abstract
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. View Abstract
Alpha-tropomyosin mutually exclusive exon selection: competition between branchpoint/polypyrimidine tracts determines default exon choice. View Abstract
Carcinogenic effects of monofunctional and bifunctional furocoumarins. View Abstract
Locations